PMGC (NASDAQ:ELAB) Stock Price Down 11.1% – Should You Sell?

PMGC Holdings Inc. (NASDAQ:ELAB) traded down 11.1% on Tuesday . The company traded as low as $4.07 and last traded at $4.39. 294,220 shares changed hands during mid-day trading, an increase of 20% from the average session volume of 244,312 shares. The stock had previously closed at $4.94.

Wall Street Analyst Weigh In

ELAB has been the subject of several analyst reports. Wall Street Zen upgraded PMGC to a “sell” rating in a report on Saturday, October 25th. Weiss Ratings reiterated a “sell (e)” rating on shares of PMGC in a research report on Monday, December 1st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

PMGC Stock Down 11.1%

The company has a market capitalization of $2.99 million, a PE ratio of -0.26 and a beta of 0.29. The stock’s fifty day moving average price is $5.70 and its two-hundred day moving average price is $6.47.

PMGC (NASDAQ:ELAB) last released its quarterly earnings results on Friday, November 14th. The company reported ($4.95) EPS for the quarter. The business had revenue of $0.29 million during the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.